Mesenchymal Stromal Cells (MSC) are a population of multipotent stromal cells that can differentiate into a variety of cell types, including osteoblasts (bone cells), chondrocytes (cartilage cells), myocytes (muscle cells) and adipocytes (fat cells which give rise to marrow adipose tissue). These characteristics give MSC’s the potential for use as living medicines, which may also exploit their capabilities in anti-inflammatory, immunomodulatory, and cell signalling activity.
The MedXCell Group believes that this treatment, currently in late-stage clinical studies, will provide a cost-effective and safe treatment for the millions of patients who experience the life-changing burden of osteoarthritis.
MSC therapy also has potential in many other indications involving mechanical tissue degeneration and chronic pain.
This website contains information about products that may not be available in all countries, available under different trademarks or for different indications. Nothing contained herein should be considered a solicitation, promotion or advertisement for any product including those under development and described on this site. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider
© All rights reserved 2021 – MedXCell SA